Compounded Injectable Tirzepatide
US$ 27.15
glp-1 agonists diabetes New Guidelines for Type 2 in 2025 Mechanisms of action of GLP-1RA.
Description
Masmiquel L, Leiter LA, Vidal J et al
Particularly where obesity rather than diabetes is the main target
GLP1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress
Manza, P
This data supports a treatment paradigm in which patients could initiate treatment with potent injectable agents for maximal initial weight loss and then transition to oral orforglipron for long-term maintenance, reducing the burden of chronic injection therapy
This update was prepared for World Obesity Day 2026
